Efficacy of 24 weeks treatment with peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C infected with genotype 1 and low pretreatment viremia.

Zeuzem, Stefan

Efficacy of 24 weeks treatment with peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C infected with genotype 1 and low pretreatment viremia. [electronic resource] - Journal of hepatology Jan 2006 - 97-103 p. digital

Publication Type: Clinical Trial, Phase IV; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

0168-8278

10.1016/j.jhep.2005.10.003 doi


Adolescent
Adult
Aged
Antiviral Agents--therapeutic use
Drug Therapy, Combination
Female
Follow-Up Studies
Genotype
Hepacivirus--genetics
Hepatitis C, Chronic--drug therapy
Humans
Interferon alpha-2
Interferon-alpha--therapeutic use
Male
Middle Aged
Polyethylene Glycols
Polymerase Chain Reaction
RNA, Viral--genetics
Recombinant Proteins
Ribavirin--therapeutic use
Time Factors
Treatment Outcome
Viremia--drug therapy